fibrinopeptide

简明释义

英[ˌfɪbrɪnəʊˈpeptaɪd]美[ˌfaɪbrənoʊˈpepˌtaɪd]

n. [生化] 血纤维蛋白肽

英英释义

单词用法

同义词

反义词

例句

1.Abstract Dynamic changes of serum fibrinopeptide a (FPA) were studied in 12 patients with acute myocardial infarction (ami) and 25 ones with unstable angina (UA).

观察了12例急性心肌梗塞(ami)和25例不稳定性心绞痛(UA)患者血浆纤维蛋白肽a (FPA)的动态变化。

2.Methods Prothrombin fragments 1 and 2 (F1+2), fibrinopeptide A (FPA), soluble fibrin monomer complex(SFMC) were examined by enzyme linked immunoassay(ELISA);

方法采用酶联免疫分析法测定凝血酶原片段1+2 （F1+2 ）、纤维蛋白肽A（FPA）、可溶性纤维蛋白单体复合物（SFMC） ；

3.Objective To observe the levels of platelet alpha-granule membrane glycoprotein 140 (GMP-140) and fibrinopeptide a (FPA) in patients with acute coronary syndromes (ACS).

目的观察急性冠状动脉综合征(ACS)患者血浆血小板膜糖蛋白140 (GMP- 140)及纤维蛋白肽a (FPA)水平的改变。

4.Objective To observe the levels of platelet alpha-granule membrane glycoprotein 140 (GMP-140) and fibrinopeptide a (FPA) in patients with acute coronary syndromes (ACS).

目的观察急性冠状动脉综合征(ACS)患者血浆血小板膜糖蛋白140 (GMP- 140)及纤维蛋白肽a (FPA)水平的改变。

5.Doctors often measure levels of fibrinopeptide to assess the risk of thrombosis.

医生通常测量纤维蛋白肽的水平以评估血栓形成的风险。

6.In patients with disseminated intravascular coagulation, fibrinopeptide levels can be significantly elevated.

在弥散性血管内凝血的患者中，纤维蛋白肽水平可能显著升高。

7.The presence of fibrinopeptide in the blood can indicate an ongoing clotting process.

血液中存在纤维蛋白肽可能表明正在进行的凝血过程。

8.The fibrinopeptide test is a useful tool for monitoring patients after surgery.

纤维蛋白肽测试是手术后监测患者的有用工具。

9.Research shows that measuring fibrinopeptide can help in diagnosing certain clotting disorders.

研究表明，测量纤维蛋白肽可以帮助诊断某些凝血障碍。

作文

The human body is a complex system that relies on various biochemical processes to maintain health and functionality. One such process is the coagulation of blood, which is essential for preventing excessive bleeding when injuries occur. Within this intricate process, a specific term often arises: fibrinopeptide. This term refers to small peptide fragments that are released during the conversion of fibrinogen to fibrin, a crucial step in the formation of a blood clot. Understanding the role of fibrinopeptide in coagulation can provide insights into both normal physiological functions and pathological conditions.Fibrinogen is a soluble plasma protein produced by the liver, and it plays a pivotal role in hemostasis. When a blood vessel is injured, the body initiates a cascade of events that lead to the conversion of fibrinogen into fibrin. This process is catalyzed by the enzyme thrombin. As thrombin cleaves fibrinogen, it releases fibrinopeptide A and fibrinopeptide B. These peptides are not just byproducts; they serve important functions in the coagulation process. For instance, fibrinopeptide A has been shown to have effects on platelet activation, which is critical for the aggregation of platelets at the site of injury.The presence of fibrinopeptide in the bloodstream can also serve as a biomarker for certain medical conditions. Elevated levels of fibrinopeptide can indicate increased thrombin activity, which may be associated with thrombotic disorders such as deep vein thrombosis or pulmonary embolism. Therefore, measuring the levels of fibrinopeptide can provide valuable information for clinicians in diagnosing and managing these conditions.Moreover, understanding the relationship between fibrinopeptide and inflammation is another area of interest for researchers. Inflammatory processes can influence the coagulation pathway, and the release of fibrinopeptide may be a response to inflammatory stimuli. This connection suggests that fibrinopeptide not only plays a role in coagulation but may also be involved in the broader context of immune responses.In summary, fibrinopeptide is a significant component of the blood coagulation process, acting as a bridge between the formation of fibrin and platelet activation. Its dual role as a participant in hemostasis and a potential biomarker for disease underscores its importance in both health and disease. As our understanding of fibrinopeptide continues to evolve, it may lead to new therapeutic strategies for managing coagulation disorders and improving patient outcomes. The exploration of fibrinopeptide and its functions highlights the intricate interplay between different biological systems and the importance of maintaining balance within the body.

人体是一个复杂的系统，依赖于各种生化过程来维持健康和功能。其中一个重要的过程是血液凝固，这对于防止在受伤时过度出血至关重要。在这个复杂的过程中，一个特定的术语经常出现：fibrinopeptide。这个术语指的是在纤维蛋白原转化为纤维蛋白的过程中释放的小肽片段，这是形成血块的关键步骤。理解fibrinopeptide在凝血过程中的作用，可以为我们提供对正常生理功能和病理状态的深入见解。纤维蛋白原是一种由肝脏产生的可溶性血浆蛋白，在止血中发挥着关键作用。当血管受伤时，身体会启动一系列事件，导致纤维蛋白原转化为纤维蛋白。这个过程是由酶凝血酶催化的。当凝血酶切割纤维蛋白原时，它释放出fibrinopeptide A和fibrinopeptide B。这些肽不仅仅是副产品；它们在凝血过程中发挥着重要的功能。例如，fibrinopeptide A已被证明对血小板激活有影响，这对在受伤部位聚集血小板至关重要。fibrinopeptide在血液中的存在也可以作为某些医疗条件的生物标志物。升高的fibrinopeptide水平可能表明凝血酶活性增加，这可能与深静脉血栓或肺栓塞等血栓性疾病相关。因此，测量fibrinopeptide的水平可以为临床医生在诊断和管理这些疾病时提供有价值的信息。此外，了解fibrinopeptide与炎症之间的关系也是研究人员感兴趣的另一个领域。炎症过程可以影响凝血途径，而fibrinopeptide的释放可能是对炎症刺激的反应。这种联系表明，fibrinopeptide不仅在凝血中发挥作用，还可能参与更广泛的免疫反应。总之，fibrinopeptide是血液凝固过程中的一个重要组成部分，充当了纤维蛋白形成与血小板激活之间的桥梁。它作为止血参与者和疾病潜在生物标志物的双重角色突显了它在健康和疾病中的重要性。随着我们对fibrinopeptide理解的不断深入，它可能会导致管理凝血障碍和改善患者结果的新治疗策略。对fibrinopeptide及其功能的探索突显了不同生物系统之间复杂的相互作用，以及维持身体平衡的重要性。